SMi’s 5th annual ADC Summit provides a comprehensive analysis of the various approaches with the next generation ADCs. Hear the latest insights from Takeda on Adcetris; discuss the latest advancements in research and development from Medimmune; and analyse case studies from big pharma companies such as Roche, Bayer, Pfizer, AstraZeneca, Novartis and many more.
Join industry experts as they share, confer and debate how to create the next wave of ADCs with better efficacy, lower toxicity and improved potency for clinical success.
Register for 2 half-day post-conference workshops
WORKSHOP A: ADC Payloads: Availability and Mechanisms of Action hosted by Femtogenix and King’s College London
WORKSHOP B: Developments in High Potency Manufacturing hosted by SKAN AG
For more information or to register visit http://www.adcsummit.com/bioscreening